Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Douglas Tsao downgraded Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) from Buy to Neutral and cut the price target from $48 to $41. Apellis Pharmaceuticals shares closed at $40.23 on Tuesday. See how other analysts view this stock.
- B of A Securities analyst Lorraine Hutchinson downgraded NIKE, Inc. (NYSE:NKE) from Buy to Neutral and slashed the price target from $73 to $55. Nike shares closed at $52.82 on Tuesday. See how other analysts view this stock.
- Citigroup analyst Patrick Cunningham downgraded PPG Industries, Inc. (NYSE:PPG) from Buy to Neutral and cut the price target from $132 to $113. PPG shares closed at $106.88 on Tuesday. See how other analysts view this stock.
- Citigroup analyst Yigal Nochomovitz downgraded Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) from Buy to Neutral and lowered the price target from $44 to $41. Apellis Pharmaceuticals shares closed at $40.23 on Tuesday. See how other analysts view this stock.
- Scotiabank analyst Orest Wowkodaw downgraded Ivanhoe Mines (TSX:IVN) from Sector Outperform to Sector Perform and cut the price target from C$19 to C$14.5. See how other analysts view this stock.
Considering buying PPG stock? Here’s what analysts think:
Photo via Shutterstock
Login to comment